IL146039A0 - A process for producing an intravenously administerable gamma globulin solution - Google Patents

A process for producing an intravenously administerable gamma globulin solution

Info

Publication number
IL146039A0
IL146039A0 IL14603900A IL14603900A IL146039A0 IL 146039 A0 IL146039 A0 IL 146039A0 IL 14603900 A IL14603900 A IL 14603900A IL 14603900 A IL14603900 A IL 14603900A IL 146039 A0 IL146039 A0 IL 146039A0
Authority
IL
Israel
Prior art keywords
producing
gamma globulin
globulin solution
administerable
intravenously
Prior art date
Application number
IL14603900A
Other languages
English (en)
Original Assignee
Alpha Therapeutic Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alpha Therapeutic Corp filed Critical Alpha Therapeutic Corp
Publication of IL146039A0 publication Critical patent/IL146039A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL14603900A 1999-05-20 2000-05-17 A process for producing an intravenously administerable gamma globulin solution IL146039A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/316,117 US6441144B1 (en) 1999-05-20 1999-05-20 Method for repairing dual virally inactivated immune globulin for intravenous administration
PCT/US2000/008222 WO2000071142A1 (en) 1999-05-20 2000-05-17 Method for preparing dual virally inactivated immune globulin for intravenous administration

Publications (1)

Publication Number Publication Date
IL146039A0 true IL146039A0 (en) 2002-07-25

Family

ID=23227544

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14603900A IL146039A0 (en) 1999-05-20 2000-05-17 A process for producing an intravenously administerable gamma globulin solution

Country Status (13)

Country Link
US (2) US6441144B1 (xx)
EP (1) EP1183036A4 (xx)
JP (1) JP2003528803A (xx)
KR (1) KR20020019916A (xx)
CN (1) CN1351500A (xx)
AU (1) AU757568B2 (xx)
BR (1) BR0010815A (xx)
CA (1) CA2371356A1 (xx)
CZ (1) CZ20013792A3 (xx)
IL (1) IL146039A0 (xx)
PL (1) PL361133A1 (xx)
WO (1) WO2000071142A1 (xx)
ZA (1) ZA200109516B (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6995246B1 (en) * 2000-10-19 2006-02-07 Akzo Nobel N.V. Methods for removing suspended particles from soluble protein solutions
ES2184594B1 (es) * 2001-01-17 2004-01-01 Probitas Pharma Sa Procedimiento para la produccion de gammaglobulina g humana inactivada de virus.
JP5037331B2 (ja) * 2004-03-19 2012-09-26 バクスター・インターナショナル・インコーポレイテッド 出血性障害の処置のための第ｉｘａ因子
TWI391399B (zh) 2005-05-25 2013-04-01 Hoffmann La Roche 測定溶離多肽之鹽濃度之方法
US20080214795A1 (en) * 2007-02-14 2008-09-04 Amgen Inc. Method of isolating antibodies by precipitation
PE20090100A1 (es) * 2007-03-30 2009-02-26 Wyeth Corp Metodos de separacion y deteccion de acetato de bacedoxifeno en composiciones farmaceuticas
WO2009046168A1 (en) 2007-10-02 2009-04-09 Avaxia Biologics, Inc. Antibody therapy for use in the digestive tract
WO2010059232A1 (en) * 2008-11-20 2010-05-27 Biogen Idec Ma Inc. Arginine inactivation of viruses
EP2519537A4 (en) * 2009-12-29 2013-07-10 Reddys Lab Ltd Dr CLEANING PROTEINS
HUE053664T2 (hu) 2011-07-18 2021-07-28 The United States Of America Eljárások és készítmények Polyomavírussal összefüggõ betegségek gátlására
CN103160486A (zh) * 2013-04-02 2013-06-19 黑龙江迪龙制药有限公司 一种猪凝血酶的制备方法
EP3313273A4 (en) * 2015-06-24 2019-03-20 The Medical College of Wisconsin, Inc. SYSTEM AND METHOD FOR LOCALIZED PROCESSING OF CARDS OF QUANTITATIVE SUSCEPTIBILITY IN MAGNETIC RESONANCE IMAGING

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2801123C2 (de) * 1977-01-26 1986-01-02 Armour Pharma GmbH & Co KG, 3440 Eschwege Verfahren zur Herstellung eines intravenös applizierbaren Serumeiweiß-Präparates
US4820805A (en) 1983-07-14 1989-04-11 New York Blood Center, Inc. Undenatured virus-free trialkyl phosphate treated biologically active protein derivatives
JPS6042336A (ja) * 1983-08-18 1985-03-06 Nippon Seiyaku Kk 免疫グロブリンの製造方法
US4835257A (en) 1984-07-07 1989-05-30 Armour Pharma Gmbh Process for preparing gamma globulin suitable for intravenous administration using peg and a citrate buffer
FR2582515B1 (fr) 1985-05-30 1988-11-04 Merieux Inst Procede de preparation de gamma-gobulines administrables par voie intraveineuse et gamma-globulines obtenues
JPH0662436B2 (ja) * 1986-05-19 1994-08-17 株式会社ミドリ十字 静注用免疫グロブリン製剤の製造方法
US4841023A (en) 1986-06-25 1989-06-20 New York Blood Center, Inc. Inactivation of viruses in labile protein-containing compositions using fatty acids
CA1310267C (en) 1986-07-09 1992-11-17 Yutaka Hirao Process for heat treating chemically unmodified _-globulin
DE3825429C2 (de) 1988-07-27 1994-02-10 Biotest Pharma Gmbh Verfahren zur Herstellung eines intravenös verabreichbaren polyklonalen Immunglobulin-Präparates mit hohem IgM-Gehalt
JP2926728B2 (ja) * 1988-12-29 1999-07-28 吉富製薬株式会社 蛋白質含有組成物の製造方法
JP2965069B2 (ja) * 1989-01-13 1999-10-18 吉富製薬株式会社 蛋白質含有組成物の製造方法
EP0378208B2 (en) 1989-01-13 2003-01-15 Mitsubishi Pharma Corporation Production method for protein-containing composition
JP3297433B2 (ja) 1989-06-15 2002-07-02 ローヌ−プーラン ローラー インターナショナル （ホウルディングス） インコーポレイテッド ウイルスで汚染された薬理組成物中のウイルスの不活性化方法
DE3927111C3 (de) * 1989-08-17 1994-09-01 Biotest Pharma Gmbh Verfahren zur Herstellung nicht modifizierter intravenös verabreichbarer IgM- und/oderIgA-haltiger Immunglobulinpräparate
US5177194A (en) 1990-02-01 1993-01-05 Baxter International, Inc. Process for purifying immune serum globulins
JP3145696B2 (ja) 1990-10-05 2001-03-12 日本ケミカルリサーチ株式会社 分泌型免疫グロブリンａ製剤の製造法
US5110910A (en) 1991-03-25 1992-05-05 Miles Inc. Virucidal euglobulin precipitation
WO1994017834A1 (de) * 1993-02-09 1994-08-18 Octapharma Ag Verfahren zur inaktivierung von viren, die nicht mit lipidhüllen versehen sind
WO1998030230A1 (fr) * 1997-01-09 1998-07-16 Yoshitomi Pharmaceutical Industries, Ltd. Compositions proteinees et procede de production

Also Published As

Publication number Publication date
CZ20013792A3 (cs) 2002-04-17
BR0010815A (pt) 2002-06-11
CA2371356A1 (en) 2000-11-30
JP2003528803A (ja) 2003-09-30
EP1183036A4 (en) 2004-12-01
EP1183036A1 (en) 2002-03-06
PL361133A1 (en) 2004-09-20
US6441144B1 (en) 2002-08-27
CN1351500A (zh) 2002-05-29
US20010044524A1 (en) 2001-11-22
US6504012B2 (en) 2003-01-07
KR20020019916A (ko) 2002-03-13
AU4641000A (en) 2000-12-12
WO2000071142A1 (en) 2000-11-30
ZA200109516B (en) 2002-11-06
AU757568B2 (en) 2003-02-27

Similar Documents

Publication Publication Date Title
EP1229125A4 (en) PROCESS FOR PRODUCING A POLYPEPTIDE
EG22225A (en) Process for producing ethylene
GB2317615B (en) Antifungal agent compound therefor process for producing the same
IL140079A0 (en) Process for producing bisphennol a
PL345125A1 (en) A process for producing an iron-dextran compound
IL146039A0 (en) A process for producing an intravenously administerable gamma globulin solution
EP1097915A4 (en) METHOD FOR PRODUCING BISPHENOL
GB9817112D0 (en) A process for forming tubular components
PL352291A1 (en) Process for making a pipa-polyol
HUP0004103A1 (en) Method for producing a shielding case
HUP0002265A3 (en) Process for producing a plasma protein-containing medicament
EP1243657A4 (en) PROCESS FOR THE PRODUCTION OF GLYCIN
IL133146A0 (en) A method for producing an isooxazolidinedione compound
IL141734A0 (en) A process for preparing an amino lactam compound
HUP0101263A3 (en) Process for producing optically active threo-3-amino-1,2-epoxy compounds
AU125946S (en) A headlamp for a cycle
IL146433A0 (en) A process for the preparation of an intravenously-administerable gamma globulin solution
HK1047278A1 (en) Process for producing dibenzothiazepine derivatives
EP1113002A4 (en) PROCESS FOR PRODUCING O-ALKYL-N-CYANOIMIDATE
AU129734S (en) A headlamp for a cycle
GB9610804D0 (en) A jig for locks
AU128293S (en) A taillight for a cycle
EP0630655A3 (en) Method of making a hemodialyzer.
HU9801024D0 (en) Process for producing pharmaceutical intermediate
SG99292A1 (en) A method for producing oxide compounds